Back Article
  • [1]

    Hai-Bo Ding, Hong Sun, Yong-Hui Feng, Qing-Hai Hu, Qi Wang, Nan Li, Qing-Qing Ma, Wen Tian, Yan-Chun Peng, Jia-Qi Chen, Jin-Li Song, Hua-Lu Cui, Hai-Long Li, Wen-Qing Geng, Tao Dong, Xiao-Xu Han, Hong Shang, 2026: Characteristics of humoral and T-cell immune responses in people living with HIV after breakthrough SARS-CoV-2 Omicron variant infection during December 2022 to January 2023, Virologica Sinica, 41, 84-96. doi: 10.1016/j.virs.2026.01.003

  • [2]

    Xin-ping LI, Hui XING, Zhe WANG, Xue-feng SI, Lian-en WANG, Hua CHENG, Wei-guo CUI, Shu-lin JIANG, Ling-jie LIAO, Hai-wei ZHOU, Jiang-hong HUANG, Hong PENG, Peng-fei MA, Yi-ming SHAO, 2007: Study of HIV-1 Drug Resistance in Patients Receiving Free Antiretroviral Therapy in China, Virologica Sinica, 22, 233-240.

  • [3]

    Jie Jia, Hong-Yi Zheng, Yu Zhao, Kai-Cheng Gao, Deshenyue Kong, Danfeng Lu, Ji-Qun Yang, Jun-Hong Mao, Xiuwen Wang, Kun-Hua Wang, Bin Su, Jian-Hua Wang, Yong-Tang Zheng, Yi-Qun Kuang, 2025: A decreased proportion of naïve MAIT cells is associated with the incomplete immune reconstitution in antiretroviral therapy-treated HIV-1 patients, Virologica Sinica, 40, 962-976. doi: 10.1016/j.virs.2025.12.003

  • [4]

    Jingliang Chen, Yaozu He, Huolin Zhong, Fengyu Hu, Yonghong Li, Yeyang Zhang, Xia Zhang, Weiyin Lin, Quanmin Li, Feilong Xu, Shaozhen Chen, Hui Zhang, Weiping Cai, Linghua Li, 2023: Transcriptome analysis of CD4+ T cells from HIV-infected individuals receiving ART with LLV revealed novel transcription factors regulating HIV-1 promoter activity, Virologica Sinica, 38, 398-408. doi: 10.1016/j.virs.2023.03.001

  • [5]

    Chengzuo Xie, Xia Jin, Wan-Wei Li, Jian-Hua Wang, 2025: Host factor Naf1 restricts HIV-1 infection of myeloid cells and compromises the capacity of dendritic cell to prime CD4+ T cell, Virologica Sinica, 40, 217-224. doi: 10.1016/j.virs.2025.03.007

  • [6]

    Chong Wang, Muhan Huang, Bingyu Guo, Xi Zhou, Zongqiang Cui, Yi Xu, Yujie Ren, 2025: Severe enterovirus A71 infection is associated with dysfunction of T cell immune response and alleviated by Astragaloside A, Virologica Sinica, 40, 451-461. doi: 10.1016/j.virs.2025.05.010

  • [7]

    Vladimir Temchura, Matthias Tenbusch, 2014: The two faces of vaccine-induced immune response: protection or increased risk of HIV infection?!, Virologica Sinica, 29, 7-9. doi: 10.1007/s12250-014-3419-9

  • [8]

    张 颖*, 白雪帆, 黄长形, 白宪光, 2004: HIV-1 Coreceptors and Coreceptor-related AIDS Therapy, Virologica Sinica, 19, 182-186.

  • [9]

    Chang Li, Wei Jin, Tao Du, Biao Wu, Yalan Liu, Robin J Shattock, Qinxue Hu, 2014: Binding of HIV-1 virions to α4β7 expressing cells and impact of antagonizing α4β7 on HIV-1 infection of primary CD4+ T cells, Virologica Sinica, 29, 381-392. doi: 10.1007/s12250-014-3525-8

  • [10]

    徐俊杰, 汪涛, 齐连权, 王海涛, 2000: The Study of a Helper T-cell Epitope in Hepatitis C Virus Non-structural 3 Protein, Virologica Sinica, 15, 318-322.

  • [11]

    Chong Wang, Bingyu Guo, Yilin Li, Xi Zhou, Zongqiang Cui, Yujie Ren, 2026: EV-A71 induces GSDME-dependent T-cell pyroptosis: A novel mechanism and MeCbl therapeutic potential, Virologica Sinica, 41, 651-661. doi: 10.1016/j.virs.2026.05.006

  • [12]

    Jun-liang FU, Fu-biao KANG, Yan-mei JIAO, Shao-jun XING, Bao-yun FU, Chun-bao ZHOU, Xi-cheng WANG, Hao WU, Fu-Sheng WANG, 2007: Frequency and Absolute Number of FoxP3+ Regulatory T Cells Correlate with Disease Progression of Chronic HIV-1 Infection, Virologica Sinica, 22, 501-508.

  • [13]

    Eman Teer, Danzil E. Joseph, Leanne Dominick, Richard H. Glashoff, M. Faadiel Essop, 2021: Expansion of GARP-Expressing CD4+CD25-FoxP3+ T Cells and SATB1 Association with Activation and Coagulation in Immune Compromised HIV-1-Infected Individuals in South Africa, Virologica Sinica, 36, 1133-1143. doi: 10.1007/s12250-021-00386-8

  • [14]

    Zhi-Tao WAN, Xu-lin CHEN, 2010: Mechanisms of HIV envelope-induced T lymphocyte apoptosis, Virologica Sinica, 25, 307-315. doi: 10.1007/s12250-010-3148-7

  • [15]

    Jiantao Fu, Yifan Guo, Guoxiang Zheng, Zongxing Yang, Jinchuan Shi, Dingyan Yan, Jianhua Yu, Lijun Sun, Hongxin Zhao, 2025: Efficacy and safety of switching from lopinavir/ritonavir-based regimens to bictegravir/emtricitabine/tenofovir alafenamide in people living with HIV: A multicenter retrospective study, Virologica Sinica, 40, 835-841. doi: 10.1016/j.virs.2025.10.003

  • [16]

    Zhihao Zhang, Wei Hou, Shuliang Chen, 0: Updates on CRISPR-based gene editing in HIV-1/AIDS therapy, Virologica Sinica.

  • [17]

    Zhihao Zhang, Wei Hou, Shuliang Chen, 2022: Updates on CRISPR-based gene editing in HIV-1/AIDS therapy, Virologica Sinica, 37, 1-10. doi: 10.1016/j.virs.2022.01.017

  • [18]

    Krystelle Nganou-Makamdop, Daniel C. Douek, 2019: Manipulating the Interferon Signaling Pathway: Implications for HIV Infection, Virologica Sinica, 34, 192-196. doi: 10.1007/s12250-019-00085-5

  • [19]

    Jia Liu, Wen Pan, Dongliang Yang, 2018: The Era of Immune Checkpoint Therapy: From Cancer to Viral Infection—A Mini Comment on the 2018 Medicine Nobel Prize, Virologica Sinica, 33, 467-471. doi: 10.1007/s12250-018-0077-3

  • [20]

    Qingrong Zhang, Lijun Sun, Yuxuan Liang, Wenlu Zou, Jingtao Huang, Yuan Zhang, Yi Jin, Na Zhou, Jiangzhu Ye, Huachun Zou, Hao Wu, Tong Zhang, Bin Su, Taiyi Jiang, Haitao Chen, 2025: Patterns of liver fibrosis evolution in Chinese HIV/HBV co-infected adults following 5-year antiretroviral treatment: A longitudinal study using non-invasive APRI and Fib-4 scores, Virologica Sinica, 40, 118-124. doi: 10.1016/j.virs.2024.12.009